Exogenous Sphingomyelinase Causes Impaired Intestinal Epithelial Barrier Function

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2007 Sep 19

PMID 17876892

Citations 22

Authors

Jurgen Bock

Gerhard Liebisch

Joachim Schweimer

Gerd Schmitz

Gerhard Rogler

Affiliations

Soon will be listed here.

Abstract

Aim: To test the hypothesis that hydrolysis of sphingomyelin to ceramide changes the composition of tight junctions (TJs) with increasing permeability of the intestinal epithelium.

Methods: Monolayers of Caco-2 cells were used as an in vitro model for the intestinal barrier. Permeability was determined by quantification of transepithelial flux and transepithelial resistance. Sphingolipid-rich membrane microdomains were isolated by a discontinuous sucrose gradient and characterized by Western-blot. Lipid content of microdomains was analysed by tandem mass spectrometry. Ceramide was subcellularly localized by immunofluorescent staining.

Results: Exogenous sphingomyelinase increased transepithelial permeability and decreased transepithelial resistance at concentrations as low as 0.01 U/mL. Lipid analysis showed rapid accumulation of ceramide in the membrane fractions containing occludin and claudin-4, representing TJs. In these fractions we observed a concomitant decrease of sphingomyelin and cholesterol with increasing concentrations of ceramide. Immunofluorescent staining confirmed clustering of ceramide at the sites of cell-cell contacts. Neutralization of surface ceramide prevented the permeability-increase induced by platelet activating factor.

Conclusion: Our findings indicate that changes in lipid composition of TJs impair epithelial barrier functions. Generation of ceramide by sphingomyelinases might contribute to disturbed barrier function seen in diseases such as inflammatory, infectious, toxic or radiogenic bowel disease.

Citing Articles

Lipidomics of Caco-2 Cells Under Simulated Microgravity Conditions.

Tolle G, Serreli G, Deiana M, Moi L, Zavattari P, Pantaleo A Int J Mol Sci. 2024; 25(23).

PMID: 39684348 PMC: 11641246. DOI: 10.3390/ijms252312638.

An untargeted metabolomic study using MALDI-mass spectrometry imaging reveals region-specific biomarkers associated with bowel inflammation.

Ponzoni A, Speca S, Hartle M, Gerstenberg A, Tomezyk A, Senechal V Metabolomics. 2024; 21(1):5.

PMID: 39674857 PMC: 11646223. DOI: 10.1007/s11306-024-02200-4.

Application of SWATH Mass Spectrometry and Machine Learning in the Diagnosis of Inflammatory Bowel Disease Based on the Stool Proteome.

Shajari E, Gagne D, Malick M, Roy P, Noel J, Gagnon H Biomedicines. 2024; 12(2).

PMID: 38397935 PMC: 10886680. DOI: 10.3390/biomedicines12020333.

Fecal sphingolipids predict parenteral nutrition-associated cholestasis in the neonatal intensive care unit.

Moutinho T, Powers D, Hanson G, Levy S, Baveja R, Hefner I JPEN J Parenter Enteral Nutr. 2022; 46(8):1903-1913.

PMID: 35285019 PMC: 9468188. DOI: 10.1002/jpen.2374.

Ceramide signaling in the gut.

Li Y, Nicholson R, Summers S Mol Cell Endocrinol. 2022; 544:111554.

PMID: 34998898 PMC: 8828712. DOI: 10.1016/j.mce.2022.111554.

References

Brugger B, Erben G, Sandhoff R, Wieland F, Lehmann W . Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci U S A. 1997; 94(6):2339-44. PMC: 20089. DOI: 10.1073/pnas.94.6.2339. View

Liebisch G, Lieser B, Rathenberg J, Drobnik W, Schmitz G . High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta. 2004; 1686(1-2):108-17. DOI: 10.1016/j.bbalip.2004.09.003. View

Grassme H, Gulbins E, Brenner B, Ferlinz K, Sandhoff K, Harzer K . Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell. 1997; 91(5):605-15. DOI: 10.1016/s0092-8674(00)80448-1. View

Kim M, Linardic C, Obeid L, Hannun Y . Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem. 1991; 266(1):484-9. View

Grassme H, Riehle A, Wilker B, Gulbins E . Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem. 2005; 280(28):26256-62. DOI: 10.1074/jbc.M500835200. View

Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A . Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003; 300(5622):1155-9. DOI: 10.1126/science.1082504. View

Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R . Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut. 2005; 54(7):966-71. PMC: 1774598. DOI: 10.1136/gut.2004.052316. View

Nusrat A, Parkos C, Verkade P, Foley C, Liang T, Eastburn K . Tight junctions are membrane microdomains. J Cell Sci. 2000; 113 ( Pt 10):1771-81. DOI: 10.1242/jcs.113.10.1771. View

Shoda R, Matsueda K, Yamato S, Umeda N . Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol. 1995; 30 Suppl 8:98-101. View

10.

Gulbins E, Kolesnick R . Raft ceramide in molecular medicine. Oncogene. 2003; 22(45):7070-7. DOI: 10.1038/sj.onc.1207146. View

11.

Leung L, Contreras R, Flores-Maldonado C, Cereijido M, Rodriguez-Boulan E . Inhibitors of glycosphingolipid biosynthesis reduce transepithelial electrical resistance in MDCK I and FRT cells. Am J Physiol Cell Physiol. 2002; 284(4):C1021-30. DOI: 10.1152/ajpcell.00149.2002. View

12.

Grassme H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H . Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med. 2003; 9(3):322-30. DOI: 10.1038/nm823. View

13.

Playford R, Ghosh S . Cytokines and growth factor modulators in intestinal inflammation and repair. J Pathol. 2005; 205(4):417-25. DOI: 10.1002/path.1722. View

14.

Yu Z, Nikolova-Karakashian M, Zhou D, Cheng G, Schuchman E, Mattson M . Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci. 2001; 15(2):85-97. DOI: 10.1385/JMN:15:2:85. View

15.

Brown D, London E . Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem. 2000; 275(23):17221-4. DOI: 10.1074/jbc.R000005200. View

16.

Ruiz-Arguello M, Basanez G, Goni F, Alonso A . Different effects of enzyme-generated ceramides and diacylglycerols in phospholipid membrane fusion and leakage. J Biol Chem. 1996; 271(43):26616-21. DOI: 10.1074/jbc.271.43.26616. View

17.

Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K . CD95 signaling via ceramide-rich membrane rafts. J Biol Chem. 2001; 276(23):20589-96. DOI: 10.1074/jbc.M101207200. View

18.

Schissel S, Keesler G, Schuchman E, Williams K, Tabas I . The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem. 1998; 273(29):18250-9. DOI: 10.1074/jbc.273.29.18250. View

19.

Holopainen J, Subramanian M, Kinnunen P . Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry. 1998; 37(50):17562-70. DOI: 10.1021/bi980915e. View

20.

JAN J, Chatterjee S, Griffin D . Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol. 2000; 74(14):6425-32. PMC: 112150. DOI: 10.1128/jvi.74.14.6425-6432.2000. View